resTORbio, Inc. (97) | Human Resources (31)
Browse by Subcategory
Recent Contracts
-
Amended and Restated Senior Executive Cash Incentive Bonus Plan
(Filed With SEC on March 15, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on March 15, 2022)
-
Form of Employment Agreement
(Filed With SEC on March 15, 2022)
-
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Therapeutics, Inc. and Anil Singhal
(Filed With SEC on September 16, 2020)
-
Amended and Restated 2018 Stock Option and Incentive Plan and forms of award agreements thereunder
(Filed With SEC on March 15, 2022)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Stewart Abbot, Ph.D
(Filed With SEC on October 8, 2020)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Nick Harvey
(Filed With SEC on September 18, 2020)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Lloyd Klickstein
(Filed With SEC on September 18, 2020)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Francisco Galimi
(Filed With SEC on September 18, 2020)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Carrie Krehlik
(Filed With SEC on September 18, 2020)
-
Employment Agreement, dated as of September 15, 2020, by and between the Company and Chen Schor
(Filed With SEC on September 18, 2020)
-
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable)
(Filed With SEC on September 16, 2020)
-
First Amendment to the Adicet Bio, Inc. 2018 Stock Option and Incentive Plan
(Filed With SEC on September 16, 2020)
-
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement
(Filed With SEC on September 16, 2020)
-
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel - 102)
(Filed With SEC on September 16, 2020)
-
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i))
(Filed With SEC on September 16, 2020)
-
Form of Adicet Therapeutics, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable)
(Filed With SEC on September 16, 2020)
-
Adicet Therapeutics, Inc. 2015 Stock Incentive Plan
(Filed With SEC on September 16, 2020)
-
Transition Agreement, dated April 28, 2020, as amended, by and between Adicet Bio, Inc. and Anil Singhal
(Filed With SEC on June 23, 2020)
-
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Restricted Stock Purchase Award Agreement
(Filed With SEC on June 23, 2020)
-
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 102)
(Filed With SEC on June 23, 2020)
-
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Israel 3(i))
(Filed With SEC on June 23, 2020)
-
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Non-Immediately Exercisable)
(Filed With SEC on June 23, 2020)
-
Form of Adicet Bio, Inc. 2015 Stock Incentive Plan Stock Option Agreement (Immediately Exercisable)
(Filed With SEC on June 23, 2020)
-
Adicet Bio, Inc. 2015 Stock Incentive Plan
(Filed With SEC on June 23, 2020)
-
Amendment to Stewart Abbots Employment Offer Letter, dated as of June 18, 2020, between Adicet Bio, Inc. and Stewart Abbot, Ph.D
(Filed With SEC on June 23, 2020)
-
Employment Offer Letter, dated as of May 17, 2018, between the Adicet Bio, Inc. and Stewart E. Abbot
(Filed With SEC on June 23, 2020)
-
Employment Offer Letter, dated as of November 1, 2017, between Adicet Bio, Inc. and Carrie A. Krehlik
(Filed With SEC on June 23, 2020)
-
Amendment to Francesco Galimis Employment Offer Letter, dated as of April 25, 2020, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D
(Filed With SEC on June 23, 2020)
-
Employment Offer Letter, dated as of September 4, 2019, between Adicet Bio, Inc. and Francesco Galimi, M.D. Ph.D
(Filed With SEC on June 23, 2020)
-
Employment Agreement, dated as of May 8, 2019, between the Company and Lloyd Klickstein
(Filed With SEC on August 14, 2019)